This is the authors' abstract. We don't add key points for this paper.
In summary, the results provide preclinical evidence, for the first time, that quantitative ultrasound used at a clinically relevant frequency, in addition to high-frequency ultrasound, can detect tissue changes associated with cell death in vivo in response to cancer treatments.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sadeghi‐Naini et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: